🇺🇸 FDA
Patent

US 7173005

Insulin and IGF-1 receptor agonists and antagonists

granted A61KA61K38/08

Quick answer

US patent 7173005 (Insulin and IGF-1 receptor agonists and antagonists) held by ANTYRA INC. expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ANTYRA INC.
Grant date
Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/08